<p>Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study</p>-Reference-Cited by-同舟云学术

Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study

Published:2020-10 Issue: Volume:Volume 9 Page:205-217
ISSN:2230-5254
Container-title:Integrated Pharmacy Research and Practice
language:en
Short-container-title:IPRP

Author:

Bahta Merhawi^ORCID,Berhe Tzeggai,Russom Mulugeta^ORCID,Tesfamariam Eyasu H^ORCID,Ogbaghebriel Azieb^ORCID

Publisher

Informa UK Limited

Subject

General Materials Science

Reference43 articles.

1. The National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Children and Young People. Great Britain: The British Psychological Society and the Royal College of psychiatrists; 2013.

2. 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)

3. Antipsychotic Treatment and Mortality in Schizophrenia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation of adverse drug events in different settings in Africa: a systematic review;European Journal of Medical Research;2024-06-16

2. Effectiveness of pharmaceutical care for improving medication‐related quality of life and adherence to treatment among people living with schizophrenia: a randomised controlled trial;Journal of Pharmacy Practice and Research;2024-02-13

3. A Clinical Audit of Psychotropic Drug Use in a Nigerian Teaching Hospital;Pharmacologia;2023-10-27

4. Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic;Mental Health Clinician;2023-02-01

5. Adverse Drug Reaction and Its Predictors Among Psychiatric Patients Taking Psychotropic Medications at the Mizan-Tepi University Teaching Hospital;Neuropsychiatric Disease and Treatment;2021-12